MCTC Holdings, Inc. (MCTC)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

Cannabis Global Closes on Definitive Agreement with Los Angeles-based Brand Whisper Weed Entering the Estimated $10B Regulated Cannabis Market

Los Angeles, CA – July 23, 2020 – Cannabis Global, Inc. (OTC:MCTC) (“Cannabis Global” or the “Company”), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, announces the closing of a definitive agreement to enter the fast-growing California cannabis delivery market.  Via the executed agreement, Whisper Weed, Inc. and Cannabis Global, have created a new California Corporation to be named CGI Whisper W, Inc., which will provide management services for the delivery entity.  CGI Whisper W, Inc, will receive 51% of the profits from the new entity, which will be recognized as income by Cannabis Global, Inc.

 

“The delivery sector is the hottest area of the California cannabis business and we are very pleased to have a seat at the table,” commented Arman Tabatabaei.  “We not only will be able to grow our revenue base relative to direct delivery, but we also see Whisper Weed as a perfect platform to launch our infusion technologies in the regulated marketplace.  With the deal closing, we are already in the process of adding other delivery platforms and other businesses to our overall portfolio.”

 

Cannabis Global views this agreement as an important step toward the verticalization of its IP-driven focus.  Many of the technologies developed for CBD and non-THC marketplaces can be directly applied to the regulated California cannabis marketplace, including the Company’s newly developed tetrahydrocannabivarin (THC-V) and Cannabinol( CBN) delivery technologies.

 

Whisper Weed Inc operates its website at www.WhisperWeedDelivery.com. Consumers are able to browse products in the flower, pre-roll, cartridge, edibles, and concentrate categories.  Consumers simply sign up on the website and order products with a delivery typically within a few hours. The operation headquartered in Downtown Los Angeles delivers to the Los Angeles metro area.  Cannabis Global believes the trend toward home delivery for cannabis is robust with further growth expected over the coming year.

 

As compensation for the Agreement, the owners of Whisper Weed, Inc. will receive $150,000 restricted common shares in the Company and shares of a newly created non-voting, participating preferred stock in Cannabis Global.  With the signing of the definitive agreement, Cannabis Global expects to begin recognizing revenues from Whisper Weed immediately.

 

Mr. Tabatabaei continued, “We have recently shifted priorities from full product development to marketing the many innovative products we have put forth into the marketplace.  This new deal with Whisper Weed is simply only one component of our overall growth programs – We have so much more planned for the Company.”

 

About Cannabis Global, Inc.

Cannabis Global, Inc. (OTC:MCTC) is a Nevada registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

 

Forward-looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

For more information, please contact:

Arman Tabatabaei

 

SOURCE: Cannabis Global, Inc.

Cannabis Global Announces Breakthrough Discovery Enabling Potential for Development of Groundbreaking Infused Products in Emerging Cannabinol (CBN) Market

Los Angeles, CA – July 16, 2020  – Cannabis Global, Inc. (OTC PINK:MCTC) (“Cannabis Global” or the “Company”), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, is excited to announce the successful application of production techniques developed for Tetrahydrocannabivarin (THC-V) to another rare cannabinoid, Cannabinol (CBN), which the Company believes may have enormous unexplored upside growth potential as a new cannabinoid-based products market.

 

This breakthrough discovery results from continued work on the Company’s “Project Varin” initiative, a core R&D effort launched in January 2020 to manufacture new nanotechnologies, infusions and consumer products based on rare cannabinoids, which has thus far yielded several important product development and production methodology breakthroughs that the Company now believes will enable more effective commercialization of products based on rare cannabinoids.

 

“Our research team has already proven our capability to produce high-quality polymeric nanoparticles and fibers of THC-V, but we also consider it important to be able to leverage our production techniques relative to other rare cannabinoids,” commented Arman Tabatabaei, CEO of Cannabis Global. “We are excited to report today the success of this effort, which comes in the form of the production of highly loaded nanofibers of CBN via our methods developed for THC-V. We believe this development allows Cannabis Global to more quickly expand our product portfolio as we continue to stake a claim in the rare cannabinoid sector, potentially unleashing underexploited growth potential in markets like CBN, with little or no real competition.”

 

The Company’s research team is nearing the completion of a subprogram of Project Varin designed to finalize high volume production methods. As part of this effort, manufactured CBN was successfully utilized, via the Company’s technologies, to produce highly loaded nanofibers. As an additional planned phase, the Company will seek to apply these established manufacturing protocols to other rare cannabinoids.

 

Mr. Tabatabaei continued, “Project Varin has exceeded our most optimistic expectations. Our next phase of CBN research will involve the design of new and innovative products based on rare cannabinoid CBN. We plan to continue programs under Project Varin throughout the second half of this year, while simultaneously launching our nature-based hemp infused products under the Hemp You Can Feel brand name. These will include our coffee products, alcohol replacement cocktail mixers, Hemp & Booch kombucha line and several other unique offerings, all based on the finest ingredients available.”

 

THC-V and CBN are not scheduled at the federal level. The Company’s THC-V products contain zero tetrahydrocannabinol (THC), far below the acceptable federal level of 0.3%, and zero heavy metals, pesticide and herbicide residues, nitrates and other impurities that are contained in most cannabis and hemp products. The Company’s products are not intended to diagnose, treat, cure or prevent any disease and are not for use by or sale to persons under the age of 18. The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.

 

About Cannabis Global, Inc.

Cannabis Global, Inc. (OTC:MCTC) is a Nevada registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

 

Forward-looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

 

For more information, please contact:
Arman Tabatabaei,
IR@cannabisglobalinc.co

 

Public Relations:

Tiger Global Management

info@TigerGMP.com

www.TigerGMP.com

 

Source: Cannabis Global, Inc.

Cannabis Global Introduces “Hemp & Booch” Super Premium Kombucha - Powered by Hemp You Can Feel™

Los Angeles, CA –  June 30, 2020 – Cannabis Global, Inc. (OTC: MCTC) (“Cannabis Global” or the “Company”), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, is excited to announce the launch of its newest line of branded products, Hemp & Booch Super Premium hemp-infused Kombucha, a revolution in the Kombucha beverage market built on the finest ingredients available and powered by the Company’s Hemp You Can Feel™ infusions.

 

“Hemp & Booch not only sets the standard for taste and purity, but also for the relaxing effect provided by the Company’s patent pending Hemp You Can Feel™ infusions,” commented Arman Tabatabaei, Cannabis Global CEO. “Our new line is based on the best all-natural ingredients available, and we believe this comes across in the taste of the products, which are now available in sample quantities.”

 

The product line, which targets the high end of the craft inspired Kombucha market, is infused using a unique honey bee hemp extract technology. Rather than using hemp extracts produced in a laboratory, like all other manufacturers, Cannabis Global has based its 100% natural product line on extracts of hemp produced by providing hemp extracts to honey bees, which in turn naturally process the extracts into a unique and naturally water-soluble infusion technology.

 

Management believes the market opportunity in the Kombucha space is underappreciated, especially given the Company’s built-in advantages in hemp infusion technology. According to Grand View Research, the global kombucha market is anticipated to reach USD $7.05 billion by 2027, growing at a CAGR of 19.7% over the forecast period, with growth driven by rising consumer consciousness around healthy dietary inputs.

 

The Company will be initially introducing three Kombuchas powered by Hemp You Can Feel™ – Concord Grape & Vanilla Bean, Pineapple Mint, and Kalmbucha, a special nighttime blend based on an exotic, caffeine-free organic African tea.

 

The ingredient lists are as follows:

 

  • Concord Grape and Vanilla Bean – Ingredients: organic concord grape juice, organic vanilla bean, organic coconut water, organic ginger, honey from organic farms, hemp extracts processed from Apis Mellifera (Honey Bees), and trace amounts of organic inulin from vegetables, organic locust bean gum.

 

  • Pineapple Mint – Ingredients: organic coconut water, organic tea, organic pineapple juice, organic mint, honey from organic farms, hemp extracts processed from Apis Mellifera (Honey Bees), and trace amounts of organic inulin from vegetables, organic locust bean gum.

 

  • Kalmbucha – Ingredients: organic coconut water, organic caffeine-free African tea, organic tart cherry juice, organic lavender, honey from organic farms, hemp extracts processed from Apis Mellifera (Honey Bees), and trace amounts of organic inulin from vegetables, organic locust bean gum.

 

Mr. Tabatabaei continued, “We have gone all out relative to the ingredients and manufacturing processes utilized to produce this super-premium line. It is an authentic ‘raw food’ product, keeping true to the healthful philosophy behind Kombucha products. We believe we are the only manufacturer able to complete the entire manufacturing process for a hemp-infused Kombucha product at room temperature allowing for full enzyme and amino acid retention. After all, consumers drink Kombucha for its health benefits, and our customers deserve the best in terms of both ingredients and production process.”

 

Hemp & Booch is already available in sample quantities by request and will be available in commercial quantities through online distribution by the end of next month.

 

About Provisional Patent Filings

Under United States patent law, a provisional application is a legal document filed in the United States Patent and Trademark Office, that establishes an early filing date, but does not mature into an issued patent unless the applicant files a regular non-provisional patent application within one year.

 

About Cannabis Global, Inc.

Cannabis Global, Inc., formerly known as MCTC Holdings, Inc., is a fully audited and reporting Company with the U.S. Securities & Exchange Commission, trading with the stock symbol MCTC.  The Company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies.  The Company does not engage in the production, distribution, or sales of any controlled substances, including marijuana.  The Company has an actively growing portfolio of intellectual property having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles.  The Company markets its consumer products under the Hemp You Can Feel brand name.  Cannabis Global launched its Project Varin early in 2020, to develop new delivery methods for rare cannabinoid Tetrahydrocannabivarin (THC-V) and to develop products based on this cannabinoid.

 

Forward-looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

For more information, please contact:
Arman Tabatabaei,
IR@cannabisglobalinc.co

 

Public Relations:

Tiger Global Management

info@TigerGMP.com

www.TigerGMP.com

 

Source:  Cannabis Global, Inc.

Cannabis Global (MCTC) Begins Initial Distribution of Industry’s First THC-V Beverages

Los Angeles, CA – May 27, 2020 – Cannabis Global, Inc. (OTC PINK: MCTC) (“Cannabis Global” or the “Company”), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, is excited to announce it has completed product development and has begun distribution of its unique tetrahydrocannabivarin (THC-V) coffee and tea products to product beta testers.

 

Pending full release of the products, the Company has implemented a 30-Day beta testing period, during which production for general release will continue.

 

Cannabis Global has integrated three internally developed technologies into the unique manufacturing process for the industry’s first THC-V beverages. The first of these is the process developed by the Company to produce 70%+ loaded THC-V, controlled release, nanoparticles utilizing laboratory-based, pharmaceutical-grade production equipment. The Company is also utilizing both its internally developed powerization and one step dosing system, ensuring precise dosing and significantly faster production. The Company has filed provisional patents on all three technologies.

 

“Our unique infusion and production technologies provide Cannabis Global with a product purity advantage as well as a clear path to low cost leadership,” commented CEO Arman Tabatabaei. “The THC-V cannabinoids are synthesized and entirely free of impurities. While there were some upfront technology development and intellectual property protection costs, we expect our ongoing variable production costs to be less than half of any potential competitor. Via our technologies, we turn one of the cannabis industry’s most expensive items – pure THC-V cannabinoids – into a cost-effective solution that sets a new standard for product purity in the cannabinoid-based products marketplace.”

 

The Company’s first THC-V beverages are three blends of super-premium coffee packaged in compostable, single-serving coffee pods and several blends of organic green, black and pu’er teas, all packaged in single-serving formats.

 

Product and technology developments were a result of the Company’s Project Varin, which was implemented last year to invent new manufacturing and infusion technologies for rare cannabinoids, such as THC-V. The Company plans to utilize the developed technologies in similar applications for other rare cannabinoids, with cannabigerol (CBG) being the likely next target for integration into the Company’s beverage products.

 

THC-V is not scheduled at the federal level. The Company’s THC-V products contain zero tetrahydrocannabinol (THC), far below the acceptable federal level of 0.3%, and zero heavy metals, pesticide and herbicide residues, nitrates and other impurities that are contained in most cannabis and hemp products. The Company’s products are not intended to diagnose, treat, cure or prevent any disease and are not for use by or sale to persons under the age of 18. The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.

 

About Cannabis Global, Inc.

 

Cannabis Global, Inc., formerly known as MCTC Holdings, Inc., is a fully audited and reporting Company with the U.S. Securities & Exchange Commission, trading with the stock symbol MCTC. The Company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. The Company does not engage in the production, distribution, or sales of any controlled substances, including marijuana. The Company has an actively growing portfolio of intellectual property having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The Company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched is Project Varin early in 2020, to develop new delivery methods for rare cannabinoid Tetrahydrocannabivarin (THV-C) and to develop products based on this cannabinoid.

 

Forward-looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

For more information, please contact:

Arman Tabatabaei,

IR@cannabisglobalinc.co

 

Source:  Cannabis Global, Inc.

Cannabis Global Patent Pending Hemp Coffee Infusion Products Approved on Amazon.com Platform

Los Angeles, CA – May 21, 2020 – Cannabis Global, Inc. (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, is excited to announce that its recently introduced Hemp You Can Feel™ Coffee has been accepted for sale on Amazon.com and that the Company has begun mass manufacturing in preparation for widespread sales and distribution.

 

The products are expected to be available for purchase on the Amazon.com platform in June. The Company will be utilizing its patent pending coffee dosing system for all related manufacturing.

 

During late January of this year, Cannabis Global announced the filing of a provisional patent on a technology that allows any manufacturer of coffee pods to simply and easily add cannabinoids, vitamins, or other active ingredients to coffee pods. An important element of this invention is the “Clean Label” system utilizing mainly organic ingredients and no chemicals, surfactants or preservatives. The Hemp You Can Feel™ Coffee product bound for Amazon will be produced on an ultra-high-speed manufacturing line, which will integrate the new dosing system. The Company believes the infusion system makes legacy dosing technologies obsolete in that the new system allows for much more accurate dosing and significantly lower production costs. Thus, the Company believes it will hold a long term cost advantage related to this product category.

 

“This is an additional example of how we are moving our IP into products to solve industry issues,” commented Arman Tabatabaei, CEO of Cannabis Global. “Dosing single service coffee pods with hemp or other ingredients is a big problem. Incumbent practices are messy, expensive, and unreliable. Our internally developed, patent pending technology is easy to integrate into production systems and represents a comprehensive solution for all of these issues.”

 

Cannabis Global expects its Hemp You Can Feel™ Coffee products to be unique on Amazon, as the cleanest label product within the hemp coffee category. The hemp infusions utilize the Company’s unique dual process that contains no chemicals of any type and pure natural honey bee cannabinoid technology. As the Company finalizes its line of Hemp You Can Feel™ sweeteners, it plans to move the new set of complimentary coffee products onto the Amazon platform as well.

 

Tabatabaei continued, “While we are very excited to have our Hemp You Can Feel™ Coffee products debut on Amazon, I cannot overemphasize the significance of having the new dosing system applied to high-speed production lines. It changes the equation for infusion of hemp extracts, vitamins, and nutraceuticals into single-serving coffee pods. We are in discussions with multiple manufacturers at present and believe our technology has the potential to become a new industry standard solution.”

 

Last month, the Company announced its Hemp You Can Feel™ line of sweeteners and coffee creamers. The new product line will feature two low-calorie sweeteners, two organic natural sweeteners, and three powdered non-dairy creamers. Each product will feature the Company’s patent pending Hemp You Can Feel™ technology, based on all-natural hemp infusions.

 

Cannabis Global Plans to market the new hemp extract sweeteners in conjunction with its Hemp You Can Feel™ Coffee products.

 

About Cannabis Global, Inc.

 

Cannabis Global, Inc. (OTC:MCTC) is a Nevada registered, fully reporting, and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The ompany is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

 

Forward-looking Statements

 

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

For more information, please contact:

Arman Tabatabaei
IR@cannabisglobalinc.com
+1-(310)-986-4929

 

Related Links

Home

 

SOURCE Cannabis Global, Inc.

MCTC Files Third Cannabinoid Delivery Patent - 4D Printed Cannabinoid and Active Ingredient Delivery System

Los Angeles, CA – October 2, 2019 – MCTC Holdings, Inc. (OTCPK:MCTCD) (OTC: MCTC) today announced the filing of its third patent relating to bioavailability and delivery of cannabinoids and other active ingredients to the human body.  The recent provisional patent filing is for a unique 4D, shape changing cannabinoid and active ingredient delivery system for beverages and some foods. In physics, the 4th dimension refers to normal three-dimensional space – length, width and depth – augmented with the fourth dimension of time. Relative to MCTC’s invention, the 4th dimension is a combination of both time and the presence of liquid as the device reacts to both in order to both change shape and to infuse beverages with cannabinoids.

 

The MCTC cannabinoid delivery system, which was developed in conjunction with Cannabis Nanosciences, Inc., is an edible 3D printed object that when placed in a beverage changes into a predetermined shape while infusing the beverage with a precise amount of cannabinoids, other active ingredients or flavorings. The technology can be used with various forms of cannabinoid infusion technologies, including MCTC patent pending cannabinoid nanoparticle technology, which utilizes a water soluble form of vitamin E as a bioenhancer.

 

“This is an additional innovation for cannabinoid delivery produced by MCTC,” commented Arman Tabatabaei, CEO of the Company.  “We see many applications for this technology both within the cannabinoid industry and relative to the delivery of other active ingredients. Recent advances in 3D printing and cannabinoid infusion make this technology possible and cost effective to produce.  We plan to commercialize this technology via an internally funded effort.”

 

This patent filing follows MCTC other recent filings on cannabinoid nanoparticles combined with d-α-Tocopheryl polyethylene glycol 1000 succinate, known as TPGS, which is a proven bioenhancer based on non-GMO sunflower oil and on an edible dissolvable nanoparticle enhanced film for delivery of cannabinoids, vitamins and other active ingredients.

 

MCTC recently announced its researchers had achieved sub-micron sized polymeric particles of cannabidiol (CBD) with and without inclusion of TPGS as a bioenhancer. Work continues on numerous other forms of polymeric nanoparticles and nanofibers containing cannabinoids and other compounds.  Additionally, the Company has developed several formulations of nanofibers for transdermal applications and other non-nanotechnology cannabinoid delivery systems.

 

Mr. Tabatabaei continued, “The polymer based nanoparticles we are developing should not be confused with the simple oil-in-water nanoemulsions being marketed as interim solutions to the food and beverage industry, as these two technologies are significantly different. The polymer based particles we are developing will allow for significant loading of active ingredients and unparalleled flexibility in creating custom cannabinoid combinations with unique performance characteristics. We believe this will be an important technology area for the cannabinoid formulation marketplace.”

 

About MCTC Holdings, Inc.

 

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain.  The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

 

More information on the Company can be viewed at www.CannabisGlobalinc.com.

 

For more information, please contact:

 

Arman Tabatabaei

IR@cannabisglobalinc.com

 

Forward-looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

SOURCE: MCTC Holdings, Inc

MCTC Holdings Outlines Corporate Strategy Focused on Developing Unique Hemp Related Intellectual Properties, Products and Technologies

Los Angeles, CA – September 10, 2019 – MCTC Holdings, Inc. (OTCPK: MCTC) today outlines its strategy to maximize shareholder value in the rapidly emerging hemp industry.  The Company is preparing to launch several unique product and technology initiatives outlined below in detail in order to achieve its plans to become a leading developer of disruptive hemp and cannabis related intellectual properties.

 

” The team at MCTC has been refining its corporate strategy for the past few weeks and the Company is now preparing to roll-out several products, initiatives, proprietary technologies and patents,” commented CEO Arman Tabatabaei.  “Our corporate strategy will be to enter into the unique and defensible sectors of the high growth hemp and cannabis marketplaces. Over the coming weeks we plan to discuss these programs with our investors in greater details, but today we offer an initial outline of what our investors should expect.”

 

  • Polymeric Solid Nanoparticles and Nanofibers – Over the past few months, the Company has been engaged in an active research program to develop cannabinoid-based nanotechnologies. With great strides being made in the laboratory, the Company plans to launch several productization programs over the coming months.  “The solid nanoparticles and nanofibers we are developing should not be confused with the very simple nanoemulsions being marketed by some companies.  We believe the technologies we are developing will offer unparalleled bioavailability and cannabinoid customization possibilities well beyond anything currently available or contemplated by most in today’s marketplace,” added CEO Tabatabaei.  “We look forward to providing additional details on our nano and other technology-based initiatives over the coming months.”

 

  • Cannabinoid Isolation Joint Venture – While cannabidiol (CBD) grabs significant headlines and consumer attention recently, the fact is CBD prices are falling and its expected the large hemp crop to be harvested over the coming weeks will cause further price erosion. With this possible pending hemp oversupply situation, MCTC has made the strategic decision to greatly limit its hemp cultivation efforts and has instead created a joint venture to isolate the more than 100 other cannabinoids in the hemp plant. In many cases, these rare cannabinoids command prices that are many times higher than CBD. The Company and its JV partner have acquired both the specialized equipment and the technical capabilities to launch this program. 

 

  • Cannabinoid Delivery Systems and Methodologies – We have developed several unique methods to more effectively deliver cannabinoids to the human body. We plan to file for patent protection for the first several of these inventions over the coming weeks. 

 

  • Super Bio-enhanced CBD – The Company believes it has developed a method to significantly boost the bioavailability of CBD by way of a unique process and formulation utilizing a proprietary formula that includes water soluble vitamin E from sunflowers. The Company plans to utilize this Super Bioenhanced CBD in several white label and direct to consumer hemp products, under the trade name “Hemp You Can Feel”. The Company has registered this trade name with the U.S. Patent and Trademark Office. Rather than seeking patent protection for the proprietary technology, the Company will treat the technology as a trade secret.  The Company is currently in the process of developing a clinical study protocol to document the unique properties of this technology. 

 

 

About MCTC Holdings, Inc.

 

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain.  The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

 

More information on the Company can be viewed at www.CannabisGlobalinc.com.

 

For more information, please contact:

 

Arman Tabatabaei

IR@cannabisglobalinc.com

 

Forward-looking Statements

 

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

SOURCE: MCTC Holdings, Inc

MCTC Holdings Adds Beverage and Hospitality Industry Veteran Jim Riley to Its Strategic Advisory Board

Los Angeles, CA –  July 24, 2019 – MCTC Holdings, Inc. (OTC PINK: MCTC) is pleased to announce another high profile addition to its Strategic Advisory Board. Jim Riley, an executive at Baja United Group and former executive at Intersect Beverage, Inc., spent nearly nine years at Ketel One Vodka as Vice President of Public Relations and Marketing and previously spent more than 15 years in business management at In-N-Out Burger and Booth Creek Ski Holdings, has agreed to join the Strategic Advisory Board effectively immediately. MCTC Holdings plans to make use of Mr. Riley’s experience as it launches its unique high bioavailability cannabis powdered drink product lines over the coming months.

 

“The addition of Mr. Riley to our Strategic Advisory Board comes at a nearly perfect time for our Company,” commented Arman Tabatabaei, CEO of the Company. “Not only will he provide sound strategic and tactical advice relative to our new cannabis-infused drink lines, he will also be instrumental in assisting in the organization of our other business entities. It is exciting to have an executive of Jim’s caliber on board with our Company. We welcome him to the MCTC family.”

 

Regarding the appointment to the Advisory Board, Mr. Riley said, “Cannabis-infused drinks are one of the fastest-growing segments of the already booming cannabis industry and represent one of the few high growth categories in the overall beverage marketplace. While I am pleased to be offered an advisory role in this Company as it moves into the beverage marketplace, there are many other areas of business in which this Company is engaged where I believe I will also be able to apply my skills to the benefit of all shareholders.”

 

Management and the board of directors MCTC Holdings believe its growing Strategic Advisory Board will become an important asset for the Company. Mr. Riley joins venture and financing industry veteran Justin Costello on advisory board and additional appoints are to be expected over the coming months.

 

About MCTC Holdings, Inc.

MCTC Holdings, Inc. is a Delaware registered publicly-traded company. The Company is in the process of entering the hemp cultivation business via a cultivation operation in Riverside County, California, and has announced plans to enter the hemp oil remediation business. Additionally, it has stated its intentions to enter the market for powdered drink mixes that contain CBD and other cannabinoids. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

 

More information on the Company can be viewed at www.CannabisGlobalinc.com.

 

For more information, please contact:

Arman Tabatabaei
IR@cannabisglobalinc.com

 

Forward-looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

SOURCE: MCTC Holdings, Inc

About MCTC Holdings


Cannabis Global, Inc. is a global player in the fast growing and highly lucrative cannabis marketplace headquartered in bustling Downtown Los Angeles, California. The Company will be involved in both the industrial hemp markets, where permitted and legal under the 2018 Farm Bill, and the legal marijuana markets as permitted and licensed by way of various state and local laws and regulations.

 

Some of our projects involve: hemp cultivation of up to 100 acres, unique powdered cannabis drinks product line and intellectual properties including patents and trademarks.

 

Cannabis Global, Inc.

Setting the standard for innovative, safe, and affordable CBD products.

 

Major growth in the cannabis and CBD sector.

 

Cannabis Global, Inc. is a global player in the fast growing and highly lucrative cannabis marketplace headquartered in bustling Downtown Los Angeles, California. The Company will be involved in both the industrial hemp markets, where permitted and legal under the 2018 Farm Bill, and the legal marijuana markets as permitted and licensed by way of various state and local laws and regulations.

 

Some of our projects involve: hemp cultivation of up to 100 acres, unique powdered cannabis drinks product line and intellectual properties including patents and trademarks.

 

Focused on results.

 

Cannabis Global Inc. is a publicly traded company focused on delivering long-term shareholder growth and results. We invest with confidence and determination to be the forefront of the cannabis and CBD revolution.

 

Focused on Innovation.

 

Cannabis Global Inc. is focused on multiple growing verticals within the global cannabis & CBD industry. This is accomplished through partnerships, acquisitions, and intellectual property.

 

Stock information: MCTC

 

MANAGEMENT

 

Arman Tabatabaei – CEO and Chairman

 

Mr. Tabatabaei is a founder and Chairman of Cannabis Global, Inc. With over 15 years of management and operations experience, he has earned a strong reputation for a numbers-based analytical approach to the management of organizations. An expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management, he has made significant progress in revamping operations of several companies over the past few years.

 

Most recently, Mr. Tabatabaei has consulted with Cannabis Strategic Ventures (OTCQB:NUGS) on various growth initiatives relative to both cannabis cultivation and the organization of new hemp-related retail operations. At Sugarmade, Inc., (OTCQB:SGMD) he has been instrumental in revamping various operations relative to the Company’s hydroponic growth supplies initiatives.

 

Previously, he consulted with large corporations to create supply chain efficiencies using mathematical models and software such as JPM, SPSS and Minitab. Arman is also well versed in the retail industry after having started and successfully selling several retail establishments.

 

Mr. Tabatabaei possesses a Master of Business Administration degree from the University of Redlands, with additional post-graduate work in predictive analysis and a Bachelor of Science degree in health sciences, with an emphasis on mathematics and physics.

 

Robert Hymers – Director

 

Mr. Robert L. Hymers is a founder and Director of Cannabis Global. Inc. He has significant experiences in the cannabis sector and as a financial executive and consultant. Mr. Hymers is the Managing Partner of Pinnacle Tax Services in Los Angeles and was previously Chief Financial Officer and Director of Marijuana Company of America, Inc. (OTC: MCOA). He currently serves as a member of the Strategic Advisory Board at MassRoots, Inc., as a consultant for Cannabis Strategic Ventures, Inc. (OTC: NUGS) and Sugarmade Inc. (OTC: SGMD), with significant experience in matters concerning tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance. Mr. Hymers holds a Master of Science in Taxation and a Bachelor’s of Science in Accountancy, in addition to a CPA license.

 

Robert also has specific tax audit experience by way of employment at Ernst & Young (EY) where he worked in the firm’s core assurance practice performing audits of publicly and privately held companies, specifically in the real estate industry. Mr. Hymers subsequently transferred to the EY’s tax practice, where he specialized in providing tax services to clients in the real estate industry. Mr. Hymers specializes in partnership taxation. In addition, He has a broad range of experience, including ASC 740 tax provision audits, FIN 48 compliance, REIT compliance, preparation of 1120, 1065, and 1120S returns, multi-state tax compliance and international tax consulting. He was also a member of EY’s National Tax Group (FSO) for several years, which services private equity firms, hedge funds and banks. Previously he was also the VP of Finance and Accounting of Everlert’s wholly owned subsidiary, Totalpost Services, Inc., located in Monrovia, California and was CFO of Global Hemp Group, Inc. (OTCQB: GBHPF).

 

Edward Manolos – Director

 

Mr. Edward Manolos a founder and Director at Cannabis Global, Inc. and is one of the most accomplished pioneers in California’s Medical Marijuana industry. In 2004, he opened the very first Medical Marijuana Dispensary in Los Angeles County under the name CMCA. He has managed and operated over thirty five dispensaries from Los Angeles to San Jose including twenty In Los Angeles Pre-ICO/Prop D. He is also credited with starting Los Angeles’ first Medical Marijuana farmers market referred to as “The California Heritage Farmer’s Market,” which attracted local and international media attention and was the first of its kind.

 

He is currently a member of the board of directors of Marijuana Company of America (OTCQB: MCOA). In 2016, Mr. Manolos was appointed to the advisory board of Marijuana Company of America and Cannabis Strategic Ventures (OTCQB: NUGS) and was tasked with identifying and structuring strategic partnerships and driving product development. Mr. Manolos is also the founder of many successful companies, such as Natural Plant Extracts of California (NPEC), located in Lynwood, CA and holds one of the first State of California issued volatile manufacturing licenses. NPEC has added distribution and delivery licenses and is locking in distribution contracts with some of the largest licensed cannabis brands in California. He is also affiliated with Everest Biosynthesis Group, a leading producer of pharmaceutical grade CBD.

 

He also co-founded Ocen Communications Inc. in 1997, which was previously traded on NASDAQ under the symbol OCEN, which was an Asia-focused internet communications service provider transmitting voice, fax, and data communications for consumers, carriers and corporations. His diverse entrepreneurial focus led him to later launch the KIWIBERRI Frozen yogurt franchise in 2005.  Mr. Manolos has also provided consulting services to numerous other companies relative to the obtainment of California and Washington marijuana retail and production licenses. Mr Manolos graduated from the University of California, Riverside with a Bachelor of Science degree in Computer Science and Business Administration.

 

Source:  https://cannabisglobalinc.com/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for MCTC Holdings, Inc. current news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF MCTC Holdings, Inc.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Sign Up & Get FREE News Alerts From FNM Today!